Is Egrifta (Tesamorelin) Legal in Minnesota?
HealthRX.com
Yes, tesamorelin is legal by prescription in Minnesota
Key numbers
- 1.4 mgDaily dose of Egrifta SV, one of the two labeled formulationsSource: dailymed.nlm.nih.gov, as cited Nov 7, 2026
- 1.28 mgDaily dose of Egrifta WR, the other labeled formulationSource: dailymed.nlm.nih.gov, as cited Nov 7, 2026
- 11.6 mgVial size of Egrifta WR, which is dosed at 1.28 mg once dailySource: dailymed.nlm.nih.gov, as cited Nov 7, 2026
See the public record for Tesamorelin
At a glance
- Federal status / FDA-approved prescription drug, approved November 10, 2010 (BLA 022505) [1]
- Approved use / Excess abdominal fat in HIV-infected adults with lipodystrophy [2]
- Labeled formulations / Egrifta SV 1.4 mg daily and Egrifta WR 1.28 mg daily; not substitutable [2][3]
- Weight loss / Not indicated; the label describes a weight-neutral effect [2]
- Compounding / No FDA category for tesamorelin on its bulk-substance or safety-risk lists [4][5][6]
- Sport / Prohibited at all times under WADA S2.2.4 [7]
What federal law says about Egrifta
The FDA approved tesamorelin as Egrifta on November 10, 2010 under application BLA 022505 [1]. The approved use is narrow: reduction of excess abdominal fat in HIV-infected adults with lipodystrophy [2]. The label also says there are no data showing it improves adherence to antiretroviral therapy [2].
Which formulations do the labels describe?
The current labels describe two formulations with different doses, and the labels state they are not substitutable [2][3]. Egrifta SV is a 2 mg vial dosed at 1.4 mg once daily by subcutaneous injection into the abdomen [2]. Egrifta WR is an 11.6 mg vial dosed at 1.28 mg once daily [3]. Both labels are dated July 29, 2026 [2][3].
Does Minnesota have its own tesamorelin rule?
Minnesota's controlled-substance schedules are set out in Minn. Stat. § 152.02 [8]. The Minnesota Board of Pharmacy home page covers licensing and online license verification for pharmacies and pharmacists [9], and the Board of Medical Practice home page covers licensing and license verification for physicians and other practitioners [10]. Neither page mentions tesamorelin or sets out a tesamorelin-specific restriction.
Questions worth asking
Is compounded tesamorelin legal in Minnesota?
FDA has not placed tesamorelin in a category on its bulk-substance lists or on its significant-safety-risk list [4][5][6]. That does not establish whether a particular compounded tesamorelin product is legal in Minnesota. Compounded drugs are not FDA-approved, and FDA does not review their safety, effectiveness or quality before they are marketed [11]. Tesamorelin is also not one of the six peptides named in HHS's draft enforcement-discretion policy for compounding: BPC-157, epitalon, KPV, MOTS-c, Semax and TB-500 [12][13].
Is tesamorelin legal in sport?
Not under anti-doping rules. WADA names tesamorelin in S2.2.4 among growth hormone releasing factors and prohibits it at all times, in and out of competition [7]. It appears on both the 2026 and the 2027 Prohibited Lists [7][14].
Frequently asked questions
Is Egrifta (tesamorelin) legal in Minnesota?
Is compounded tesamorelin legal in Minnesota?
What is Egrifta approved to treat?
Is the dose 2 mg daily?
References
Show all 14 referencesHide references
- Drugs@FDA: FDA-Approved Drugs.
- U.S. National Library of Medicine, DailyMed. Egrifta SV (tesamorelin) for injection, 2 mg vial prescribing information. Egrifta SV (tesamorelin) for injection, 2 mg vial label
- U.S. National Library of Medicine, DailyMed. Egrifta WR (tesamorelin) for injection, 11.6 mg vial prescribing information. Egrifta WR (tesamorelin) for injection, 11.6 mg vial label
- Certain Bulk Drug Substances for Use in Compounding that May Present Significant Safety Risks | FDA.
- U.S. Food and Drug Administration.
- U.S. Food and Drug Administration.
- World Anti-Doping Agency.
- Sec. 152.02 MN Statutes.
- Official web page.
- Official web page.
- Human Drug Compounding Laws | FDA.
- Official web page.
- Official web page.
- World Anti-Doping Agency.